Moenomycin Complex
(Synonyms: 黄霉素) 目录号 : GC44241Moenomycin Complex是莫诺霉素A、A12、C1、C3和C4的混合物,是从几种链霉菌中分离出来的,可直接抑制细菌肽聚糖糖基转移酶(PGT)。
Cas No.:11015-37-5
Sample solution is provided at 25 µL, 10mM.
Moenomycin Complex is a mixture of moenomycin A, A12, C1, C3 and C4 isolated from several Streptomyces species that directly inhibit bacterial peptidoglycan glycosyltransferases (PGTs)[1, 2]. Moenomycin A is a member of the phospholipid antibiotic family, which is the only known natural product that directly targets extracellular PGTs involved in bacterial cell wall biosynthesis[3]. The minimum inhibitory concentration of moenomycin A against various Gram-positive bacteria ranges from 1 to 100ng/mL[4]. Moenomycin can be used as a feed additive and growth promoter[5].
References:
[1] Zehl M, Pittenauer E, Rizzi A, et al. Characterization of moenomycin antibiotic complex by multistage MALDI-IT/RTOF-MS and ESI-IT-MS[J]. Journal of the American Society for Mass Spectrometry, 2006, 17: 1081-1090.
[2] Yuan Y. Targeting the bacterial cell wall-structural insight into peptidoglycan glycosyltransferases and moenomycin inhibition[M]. Harvard University, 2008.
[3] Ostash B, Saghatelian A, Walker S. A streamlined metabolic pathway for the biosynthesis of moenomycin A[J]. Chemistry & biology, 2007, 14(3): 257-267.
[4] Ostash B, Walker S. Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity[J]. Natural product reports, 2010, 27(11): 1594-1617.
[5] Tang Y, Yang G, Ma Y, et al. Development, validation, and implementation of an ultratrace analysis method for the determination of moenomycin A, in aquatic animal products[J]. Analytical and Bioanalytical Chemistry, 2024, 416(3): 745-757.
Moenomycin Complex是莫诺霉素A、A12、C1、C3和C4的混合物,是从几种链霉菌中分离出来的,可直接抑制细菌肽聚糖糖基转移酶(PGT)[1, 2]。Moenomycin A是磷脂类抗生素家族的成员,磷脂类抗生素是已知的唯一直接靶向参与细菌细胞壁生物合成的细胞外PGT的天然产物[3]。Moenomycin A对各种革兰氏阳性菌的最低抑菌浓度范围为1-100ng/mL[4]。Moenomycin能够用作饲料添加剂和生长促进剂[5]。
Cas No. | 11015-37-5 | SDF | |
别名 | 黄霉素 | ||
Canonical SMILES | O[C@H]1[C@@H](O)[C@H](O)[C@](O[C@H]2[C@H](C)O[C@@](O[C@H]3[C@H](C[R3])O[C@@](O[C@H]4[C@H](OC(C)=O)C([R2])([R1])[C@H](C(N)=O)O[C@H]4OP(OC[C@@H](C(O)=O)OC/C=C(CC/C=C\C(C)(C)CCC(C/C=C(C)/CC/C=C(C)/C)=C)/C)(O)=O)([H])[C@@H](NC(C)=O)[C@@H]3O)([H])[C@@H](N | ||
分子式 | C69H107N4O35P (for A) | 分子量 | 1583.6 |
溶解度 | DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble | 储存条件 | Store at -20°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 0.6315 mL | 3.1574 mL | 6.3147 mL |
5 mM | 0.1263 mL | 0.6315 mL | 1.2629 mL |
10 mM | 0.0631 mL | 0.3157 mL | 0.6315 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet